Closed
SectorHealthcare
8.19 1.87
24h
Min
7.91
Max
8.19
Income | -13M 1.4M |
---|---|
Sales | -7.9M 60M |
P/E Sector Avg | 201 63.778 |
EPS | 0.01 |
Profit margin | 2.387 |
Employees | 130 |
EBITDA | -14M 7.2M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +19.05% upside |
Next Earnings | 1 maj 2025 |
---|
Market Cap | -13M 1.1B |
---|---|
Previous open | 6.32 |
Previous close | 8.19 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 9.75 USD 19.05%
High 11 USD
Low 8 USD
Based on 4 Wall Street analysts offering 12 month price targets forAurinia Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$